Contractility and phenotype transitions in serosal thickening of obstructed rabbit bladder.
Partial outlet obstruction of rabbit bladder induces serosal thickening and smooth muscle (SM) cell hypertrophy that are accompanied by phenotypic changes in the expression of cytoskeletal and cytocontractile proteins. In the present study, we compare the observed progressive phenotypic changes with the contractile responses of strips of the thickened serosa. At 15 days after partial outlet obstruction, although cells in thickened serosa demonstrate the presence of nonmuscle (NM) myosin of A-like type, vimentin, and SM alpha-actin, no contractile responses of this tissue were noted. At later times (30 days), this tissue expressed in addition SM myosin, and this pattern was paralleled by the development of KCl-stimulated contractility. It is only after 60 days that the serosa demonstrated the expression of desmin, phosphoglucomutase (PGM)-related protein, and was locally negative for NM myosin, indicating a maturation toward adult SM cells. Concomitant to this phenotypic change, the response to KCl increased, and a bethanechol-stimulated contractile response developed. At no time period did the serosal layer react with anti-synaptophysin or anti-neurofilament proteins nor did the strips respond to field stimulation (via release of neurotransmitters), showing that SM cell differentiation and development of contractile responses during serosal thickening are independent of innervation.
Roelofs
M
M
Division of Urology, University of Pennsylvania, Philadelphia 19104, USA.
Wein
A J
AJ
Monson
F C
FC
Passerini-Glazel
G
G
Koteliansky
V E
VE
Sartore
S
S
Levin
R M
RM
D000818:Animals; D018723:Bethanechol / Q000494:pharmacology; D003598:Cytoskeletal Proteins / Q000378:metabolism*; D003599:Cytoskeleton / Q000378:metabolism*; D005455:Fluorescent Antibody Technique; D007150:Immunohistochemistry; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology*; D009130:Muscle, Smooth / Q000187:drug effects / Q000294:innervation / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D010641:Phenotype; D011189:Potassium Chloride / Q000494:pharmacology; D011817:Rabbits; D011976:Receptors, Muscarinic / Q000187:drug effects / Q000378:metabolism; D001748:Urinary Bladder Neck Obstruction / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology
D003598:Cytoskeletal Proteins; D011976:Receptors, Muscarinic; D018723:Bethanechol; D011189:Potassium Chloride